News and Announcements
CleanTech company receives DA approval for one of its primary assets
- Published August 11, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Broula King Enterprises (BKE) is integrating abandoned mining assets, research capacity, environmental imperatives, rehabilitation outcomes, and innovative thinking to propel the processing of mining waste and restoration of legacy mine sites into a new dimension around ESG values and circular economy principles.
The company is pleased to announce the approval of DA2020/146 by Bathurst Shire Council for its Sunny Corner Mine, a critical step in obtaining its mining license. Approval of the DA enables BKE to progress the full approval of Mining Lease Application 593, which is now undergoing the process at NSW MEG (Minerals, Environment, and Geoscience), Department of Regional NSW. Once the license is granted, BKE will be able to commence work.
In an Australia Institute submission to a Federal Parliament Committee on abandoned mines in 2017, the legacy Sunny Corner mine was listed in the top 7 most hazardous, polluting sites in NSW that sit on Crown Land. MLA 593 has an inferred JORC resource of 1.5million tonnes of ore.
After high-level discussions with NSW MEG, the BKE project of Reclaiming, Recycling, and Remediating abandoned mine sites, alongside its MOUs with Australian universities on Critical Mineral recovery, meets every objective of NSW government’s $130M Critical Minerals and High Tech Metals Activation Fund.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
